<DOC>
	<DOC>NCT00210210</DOC>
	<brief_summary>The surgery of breast cancer is responsible for post-operative pain, needing in about 30% some morphine consumption; like that, the association of ketamine with general anaesthesia may decrease morphine's use and so its adverse effects. The purpose is to evaluate the analgesic effect of a receptor NMDA's antagonist ( ketamine)</brief_summary>
	<brief_title>Administration of Ketamine to Prevent the Post-operative Pain</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Inclusion criteria: Patients 18 years older ASA class 1 or 2 with surgery of breast cancer (mastectomy or tumorectomy) Exclusion criteria: .KÃ©tamine hypersensitivity Major psychiatric disorders Major cardiovascular disorders Major neurologic disorders Major ocular disorders Morphine in preoperative period</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Post-operative-pain</keyword>
	<keyword>Breast cancer</keyword>
	<keyword>Morphine</keyword>
	<keyword>Analgesia</keyword>
</DOC>